LPL Financial’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,134
Closed -$42.2K 5467
2025
Q1
$42.2K Buy
4,134
+54
+1% +$551 ﹤0.01% 5036
2024
Q4
$56.9K Sell
4,080
-303
-7% -$4.23K ﹤0.01% 4966
2024
Q3
$85.5K Buy
4,383
+1,097
+33% +$21.4K ﹤0.01% 4815
2024
Q2
$61.1K Buy
3,286
+920
+39% +$17.1K ﹤0.01% 4718
2024
Q1
$33.2K Sell
2,366
-1
-0% -$14 ﹤0.01% 4725
2023
Q4
$20.1K Hold
2,367
﹤0.01% 4665
2023
Q3
$21.1K Buy
2,367
+1,673
+241% +$14.9K ﹤0.01% 4543
2023
Q2
$5.99K Sell
694
-3
-0.4% -$26 ﹤0.01% 4522
2023
Q1
$7.35K Buy
697
+2
+0.3% +$21 ﹤0.01% 4436
2022
Q4
$23.6K Sell
695
-703
-50% -$23.8K ﹤0.01% 4324
2022
Q3
$67K Buy
1,398
+10
+0.7% +$479 ﹤0.01% 4151
2022
Q2
$79K Sell
1,388
-743
-35% -$42.3K ﹤0.01% 4137
2022
Q1
$172K Sell
2,131
-53
-2% -$4.28K ﹤0.01% 3844
2021
Q4
$443K Buy
2,184
+129
+6% +$26.2K ﹤0.01% 3373
2021
Q3
$554K Sell
2,055
-87
-4% -$23.5K ﹤0.01% 3111
2021
Q2
$551K Buy
2,142
+42
+2% +$10.8K ﹤0.01% 3067
2021
Q1
$630K Buy
2,100
+33
+2% +$9.9K ﹤0.01% 2818
2020
Q4
$527K Buy
2,067
+348
+20% +$88.7K ﹤0.01% 2698
2020
Q3
$428K Sell
1,719
-144
-8% -$35.9K ﹤0.01% 2585
2020
Q2
$647K Buy
1,863
+195
+12% +$67.7K ﹤0.01% 2151
2020
Q1
$447K Buy
1,668
+225
+16% +$60.3K ﹤0.01% 2160
2019
Q4
$467K Buy
1,443
+144
+11% +$46.6K ﹤0.01% 2429
2019
Q3
$355K Sell
1,299
-283
-18% -$77.3K ﹤0.01% 2537
2019
Q2
$845K Sell
1,582
-58
-4% -$31K ﹤0.01% 1846
2019
Q1
$826K Buy
1,640
+373
+29% +$188K ﹤0.01% 1781
2018
Q4
$625K Buy
1,267
+889
+235% +$439K ﹤0.01% 1860
2018
Q3
$346K Buy
378
+17
+5% +$15.6K ﹤0.01% 2540
2018
Q2
$264K Buy
361
+136
+60% +$99.5K ﹤0.01% 2749
2018
Q1
$359K Buy
+225
New +$359K ﹤0.01% 2433